Cargando…
To screen or not to screen women for Group B Streptococcus (Streptococcus agalactiae) to prevent early onset sepsis in newborns: recent advances in the unresolved debate
Streptococcus agalactiae, also known as Group B streptococcus (GBS) is the commonest cause of early onset sepsis in newborns in developed high-income countries. Intrapartum antimicrobial (antibiotic) prophylaxis (IAP) is recognized to be highly effective in preventing early onset Group B sepsis (EOG...
Autores principales: | Rao, Guduru Gopal, Khanna, Priya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361483/ https://www.ncbi.nlm.nih.gov/pubmed/32704370 http://dx.doi.org/10.1177/2049936120942424 |
Ejemplares similares
-
Streptococcus agalactiae
por: Faro, Sebastian
Publicado: (1993) -
Early-onset group B Streptococcus (EOGBS) infection subsequent to cessation of screening-based intrapartum prophylaxis: findings of an observational study in West London, UK
por: Gopal Rao, Guduru, et al.
Publicado: (2017) -
Population genetics of group B Streptococcus from maternal carriage in an ethnically diverse community in London
por: Jamrozy, Dorota, et al.
Publicado: (2023) -
Complicated Streptococcus agalactiae Sepsis with/without Meningitis in Young Infants and Newborns: The Clinical and Molecular Characteristics and Outcomes
por: Lin, Chih, et al.
Publicado: (2021) -
The essential genome of Streptococcus agalactiae
por: Hooven, Thomas A., et al.
Publicado: (2016)